Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Zetia

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zetia was produced by Merck & Co. and Bayer.

Esperion craters as deaths mar atherosclerosis drug study

Esperion craters as deaths mar atherosclerosis drug study

earlier phase III trial and the company has reiterated its plans to file for approval as a monotherapy and in combination with Merck &Co/MSD’s Zetia (ezetimibe) in the US

CETP inhibitor class finally dies as Merck abandons anacetrapib

CETP inhibitor class finally dies as Merck abandons anacetrapib Some have argued that the company should file given its big investment in the project and established commercial infrastructure, which succeeded in turning another cholesterol-lowering drug with lacklustre data - Zetia

Merck & Co's anacetrapib data fails to generate much excitement

Merck & Co's anacetrapib data fails to generate much excitement selling Zetia (ezetimibe) and Vytorin (ezetimibe/simvastatin) in this therapeutic area despite a small effect on cardiovascular outcomes.

First round to Amgen in PCSK9 patent battle with Sanofi

First round to Amgen in PCSK9 patent battle with Sanofi For example, some payers are insisting that patients on statins try adding Merck &Co's selective cholesterol-absorption inhibitor Zetia (ezetimibe) before moving on to a PCSK9 inhibitor.

NICE backs Repatha but rejects cholesterol rival Praluent

NICE backs Repatha but rejects cholesterol rival Praluent Specifically, the UK watchdog said it was concerned that unlike Repatha Praluent has not been compared to the existing combination therapy of a statin plus MSD's Zetia (ezetimibe) in clinical

1 2 3 4 5 6 7 8 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics